PATENT CLAIM ANALYSIS

Application Number: 15959430
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["424", "204100"]

Abstract:
The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains. Such antibodies are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of influenza.

Claim (Index 43):
A method of treating a subject, the method comprising steps of:\n administering to a subject suffering from or susceptible to influenza infection therapeutically effective amount of an antibody agent that: (a) has a heavy chain variable region that:\n (i) shows at least 99% substantial sequence homology with that of heavy chain variable region of SEQ ID NO: 1; and \n (ii) shares at least one CDR with SEQ ID NO:1; and \n (b) has a light chain variable region that shows at least 99% substantial sequence homology to one of SEQ ID NOs: 33-43.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 91.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13829675', '15595407', '13500879', '13830367', '14233719']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776673265037894
- 35 USC 102 Novelty (BERT): 0.5772157940701553
- Combined Prediction Score: 0.7567275179411201
- Mean Citation Score: 403.744472
- Max Citation Score: 488.5606
- Similarity Product: 401.7845951075554

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test